Metraipolis › archive › dc_d1aa387e47fa
Investment Opportunities for mRNA Technology in Low- and Middle-Income Countries: Key Findings and Future Perspectives — Europe PMC PMID:40006659
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40006659
- DOI
- 10.3390/vaccines13020112
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T16:32:31.191Z
- SHA-256 of the archived text
dbe2757a24172036a78044bab0ec2446070c4d6d319473c9b2fdd6b75cc8171f- Stable URL of this page
https://metraipolis.com/documento/dc_d1aa387e47fa
How to cite
Investment Opportunities for mRNA Technology in Low- and Middle-Income Countries: Key Findings and Future Perspectives — Europe PMC PMID:40006659 — Europe PMC (en), https://europepmc.org/article/MED/40006659 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d1aa387e47fa (Metraipolis archive dc_d1aa387e47fa, sha256 dbe2757a24172036a78044bab0ec2446070c4d6d319473c9b2fdd6b75cc8171f)
BibTeX
@misc{dcd1aa387e47fa,
title = {Investment Opportunities for mRNA Technology in Low- and Middle-Income Countries: Key Findings and Future Perspectives — Europe PMC PMID:40006659},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40006659},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d1aa387e47fa; sha256 dbe2757a24172036a78044bab0ec2446070c4d6d319473c9b2fdd6b75cc8171f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40006659. Agents can read the archived copy with the MCP tool read_document.